REFERENCES
- Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381–396.
- Schimpff S, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284: 1061–1065.
- De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly P. Ceftazidime compared with piperacillin and tobramycin for empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 1994; 120: 834–844.
- Pizzo PA, Hathorn JW, Hiemenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552–558.
- Rolston KVI, Berkey P, Bodey GP, et al. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch Intern Med 1992; 152: 283–291.
- Liang R, Yung R, Chiu E, et al. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neu-tropenic patients. Antimicrob Agents Chemother 1990; 34: 1336–1341.
- Winston DJ, Winston GH, Bruckner DA, Champlin RE. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus pipercillin and imipenem alone. Ann Intern Med 1991; 115: 849–859.
- Freifeld AG, Walsh T, Marshall D, et al. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol 1995; 13: 165–176.
- Pizzo PA, Robichaud RN, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101–111.
- Pizzo AP. After empiric therapy: what to do until the granulocyte comes back. Rev Infect Dic 1987; 9: 214–219.
- The EORTC International Antimicrobial Therapy Project Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692–1698.
- Kahan FM, Kropp H, Sundelof JG, Birnbaum J. Thienamycin: development of imipenem-cilastatin. J Antimicrob Chemother 1983; 12 (Suppl. D): 1-35.
- Bodey GP, Rolston K, Jones P, Alvares ME, Fainstein V, Steelhammer L. Imipenem/cilastatin as secondary therapy for infections in cancer patients. J Antimicrob Chemother 1986; 18: 161–166.
- Engervall P, Stiemstedt G, Giinther G, Björkholm M. Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders. J Chemother 1992; 4: 99–106.
- Engervall P, Giinther G, Ljungman P, et al. Trimethoprim-sulfamethoxazole plus amikacin versus cef-tazidime monotherapy as empirical treatment in patients with neutropenia and fever. Scand J Infect Dis 1996; 28: 297–303.
- Immunocompromised Host Society. The design, analy-sis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Inf Dis 1990; 161: 397–401.
- Novgkova IRO, Donnelly JP, De Pauw B. Potential sites of infection that develop in febrile neutropenic patients. Leukemia Lymphoma 1993; 10: 461–467.
- Kappers-Klunne MC, Degener JE, Stijnen T, AbeIs J. Complications from long-term indwelling central venous catheters in haematologic patients with special reference to infection. Cancer 1989; 64: 1742–1752.
- Refsahl K, Andersen BM. Clinically significant coagu-lase-negative staphylococci: identification and resistance pat-terns. J Hosp Infect 1992; 22: 19–31.
- Tripodi MF, Attanasio V, Adinolfi LE, et al. Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci. Eur J Clin Microbiol Infect Dis 1994; 13: 148–152.
- Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105–113.
- EORTC international antimicrobial therapy cooperative group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668–672.